Smartseq reagent kits
Closed Pre-Solicitation Posted
- Solicitation number
- SS-NIAID-24-2226785
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Rockville, Maryland 20852, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Paragraph 1:
The National Institutes of Allergy & Infectious Disease (NIAID) is seeking information on domestically manufactured products that are equal to specific SmartSeq reagent kits, including 10x Lysis Buffer, SMARTScribe RT, RNAse Inhibitor, and SeqAmp DNA Polymerase. The essential specifications and capabilities needed are detailed in the notice. Interested vendors must submit a capability statement demonstrating an equal U.S.-manufactured product by July 19, 2024, at 11:00 AM EST. The government will use the information provided to potentially issue a pre-solicitation synopsis and solicitation at a later date.
Paragraph 2:
This is a sources sought notice with no set-aside designation. The government has not identified any incumbent contractors or provided information on potential award values or budgets. The notice specifies quantities needed for each reagent kit component.
Notice text
This is a Sources Sought notice for domestically manufactured products only. This is NOT a solicitation for proposals, proposal abstracts, or quotations. Per the Buy American Act and Executive Order 14005, the National Institutes of Allergy & Infectious Disease (NIAID) is seeking information for domestically manufactured products only, Per the requirements under the Buy American Act and requirements relating to Executive Order 14005 entitled: “Ensuring the Future is Made in All of America by All of America’s Workers”, in the event that a nonavailability waiver request submitted through the Made in America Office (MIAO)’s Digital Waiver Portal is required." Respondents must certify in capabilities statement that products are manufactured in the United States.
The purpose of this notice is to obtain information regarding the availability and capability of all U.S manufactured products that are equal to the following product:
WE ARE SEEKING SMARTSEQ REAGENT KITS: 10x Lysis Buffer to efficiently disrupt cellular membranes for the release of RNA; Reverse Transcriptase for the initiation of unbiased cDNA synthesis, allowing for amplification and library construction from any RNA transcript; RNAse Inhibitor to prevent the degradation of the cellular RNA; and DNA Polymerase, a high-fidelity PCR enzyme with hot start capabilities that is especially well suited for use with specific SMARTer kits for transcriptome analysis (NGS).
The essential specifications and capabilities needed are:
1. 10x Lysis Buffer, Catalog#: 635013, QTY of 1
2. SMARTScribe RT, Catalog#: 639538, QTY of 12
3. RNAse Inhibitor, Catalog#: 2313B, QTY of 12
4. SeqAmp DNA Polymerase, Catalog#: 638509, QTY of 10
Capability Statement/Information Sought
All capable vendors should respond with a brief capability statement demonstrating an equal product that is manufactured in the United States by July 19, 2024, by 11:00 AM EST.
Capabilities statement must also include the following information: 1) organization name, address, point of contact, email address, website address, telephone number, UE ID# with an active SAM.gov registration, and a tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of capability.
Submission Instructions
Interested businesses who consider themselves qualified to provide an equal product that is manufactured in the United States for the above-listed product are invited to submit a response to this Sources Sought Notice by July 18, 2024, by 11:00 AM EST. All responses under this Sources Sought Notice must be emailed to directly to, Kimberly Rubio: kimberly.rubio@nih.gov with the Sources Sought ID# SS-NIAID-24-2226785 in email the subject line.
Disclaimer and Important Notes
This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation.
Confidentiality
No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity